x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001129
| Product Information | |
|---|---|
| Product Name | Human HNF-4-α Antibody Pair - BSA and Azide free |
| Species | Human |
| Description | The Antibody Pair can be used to quantify Human HNF-4α. BSA and Azide free antibody pairs include unconjugated capture and detector antibodies suitable for sandwich ELISAs. The antibodies are provided at an approximate concentration of 1 mg/mL as measured by the protein A280 method. The recommended antibody orientation is based on internal optimization for ELISA-based assays. Antibody orientation is assay dependent and needs to be optimized for each assay type. Both capture and detector antibodies are rabbit monoclonal antibodies delivering consistent, specific, and sensitive results. |
| Detection Range | 31.25 pg/mL - 2000 pg/mL |
| Target Information | |
|---|---|
| Target Name | HNF4A |
| UniProt No. | P41235 |
| Gene ID | 3172 |
| Target Description | Transcriptionally controlled transcription factor. Binds to DNA sites required for the transcription ofα 1-antitrypsin, apolipoprotein CIII, transthyretin genes and HNF1-α. May be essential for development of the liver, kidney and intestine. |
| Alternative Names | FLJ39654; FRTS4; Hepatic nuclear factor 4α; Hepatocyte nuclear factor 4; Hepatocyte nuclear factor 4α; Hepatocyte nuclear factor 4-α; HNF 4; HNF 4α; HNF-4-α; HNF4; HNF4A; HNF4A_HUMAN; HNF4a7; HNF4a8; HNF4a9; Hnf4α; HNF4α10/11/12; MODY; MODY 1; MODY1; NR2A1; NR2A21; Nuclear receptor subfamily 2 group A member 1; OTTHUMP00000031060; OTTHUMP00000031062; TCF; TCF 14; TCF-14; TCF14; Tcf4; Transcription factor 14, hepatic nuclear factor; Transcription factor 14; Transcription factor HNF 4; Transcription factor HNF-4; Transcription factor HNF4 |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
